Myriad, Rival Strike Deal In Cancer-Test Patent Dispute
Overview
McDermott was noted for representing Gene by Gene in its settlement of a suit brought by Myriad Genetics Inc. over alleged infringement of its cancer-testing patents.
We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.
